--- title: "Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204's Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration" description: "New Positive Preclinical Data Shows Succesful Drug Distribution to Liver, Peritoneum, and Lung with Measurable Reductions in Tumor Burden at Clinically Relevant Doses ..." type: "news" locale: "en" url: "https://longbridge.com/en/news/256914425.md" published_at: "2025-09-11T11:38:39.000Z" --- # Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204's Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration > New Positive Preclinical Data Shows Succesful Drug Distribution to Liver, Peritoneum, and Lung with Measurable Reductions in Tumor Burden at Clinically Relevant Doses ... New Positive Preclinical Data Shows Succesful Drug Distribution to Liver, Peritoneum, and Lung with Measurable Reductions in Tumor Burden at Clinically Relevant Doses ... ### Related Stocks - [SLXN.US - Silexion Therapeutics](https://longbridge.com/en/quote/SLXN.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Silexion Therapeutics 发布 2025 年股东信,重点介绍了其重大成就 | Silexion Therapeutics Corp. 发布了首席执行官 Ilan Hadar 的股东信,强调了 2025 年的主要成就,包括 SIL204 的积极临床前数据和监管毒理学研究的完成。信中还提到德国联邦药品和医疗器械研究所对 | [Link](https://longbridge.com/en/news/271656749.md) | | Silexion Therapeutics 报告称,SIL204 在 KRAS 突变癌症中显示出强效的临床前肿瘤抑制作用 | Silexion Therapeutics Corp. 报告了其 RNAi 疗法 SIL204 的强劲前临床结果,该疗法在 KRAS 突变癌症中显示出显著的肿瘤抑制效果,包括胰腺癌、结直肠癌和肺癌。这些发现是在 2025 年取得的,计划在 | [Link](https://longbridge.com/en/news/271650194.md) | | 斥资 185 亿美元牵手石药集团后,阿斯利康每股收益预增双位数 | 阿斯利康预计 2026 年每股收益将实现两位数增长,肿瘤药物销售强劲有望抵消糖尿病药物专利到期影响。公司近期以高达 185 亿美元引入石药集团长效肽技术,加速布局 GLP-1 减肥药市场。尽管面临美国药价政策调整,公司通过协议获得关税豁免。 | [Link](https://longbridge.com/en/news/275425282.md) | | 忘掉 AI 股票:这家制药巨头正在通过 AI 主导药物研发 | 而且还有多种方式可以将这项技术变现 | [Link](https://longbridge.com/en/news/276017486.md) | | 凯瑟琳·欧哈拉的死因已被确认 | 凯瑟琳·欧哈拉的死因被确认为肺栓塞,直肠癌是其潜在因素。这位在一月份去世、享年 71 岁的女演员,自去年三月以来一直在接受治疗。肺栓塞发生在血块阻塞肺部血流时,如果不及时治疗,可能会致命。欧哈拉还患有一种罕见的疾病,称为内脏反转,导致她的心 | [Link](https://longbridge.com/en/news/275452756.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.